University of Patras
Μελέτη του ρόλου του αυξητικού παράγοντα πλειοτροπίνη και υποδοχέων της σε διαδικασίες που αφορούν στην αλληλεπίδραση καρκινικών κυττάρων προστάτη με οστεοβλάστες και στην αγγειογένεση
Abstract
dc:descriptionPleiotrophin (PTN) is a growth factor that appears to play an important role in prostate cancer growth and angiogenesis and may play a role in bone growth and remodeling. PTN exerts its activities through receptor with protein tyrosine phosphatase receptor zeta 1 (PTPRZ1), ανβ3 integrin, and cell membrane nucleolin. PTN also regulates the angiogenic actions of vascular endothelial growth factor A (VEGF-A); the latter is expressed by pro-osteoblasts and has autocrine and paracrine actions, inducing the proliferation, migration, and differentiation of osteoblasts, as well as bone angiogenesis. VEGF-A expression is elevated in cases of prostate cancer and is associated with osteoblastic tumor metastasis. Recent studies of our research team have shown that PTN and VEGF-A compete for binding to PTPRZ1 and PTPRZ1 appears to be involved in the effect of VEGF-A on endothelial cell migration. Based on the above, in the present thesis, the role of PTN in the proliferation, migration and differentiation of osteoblasts, as well as in the survival and the ability of prostate cancer cells to adhere to osteoblasts was studied. In addition, the interaction of PTN with VEGFR2 in endothelial cells and osteoblasts was investigated and the functional significance of this interaction was studied. PTN has been found to be expressed in Saos-2, MG-63 and MC3T3-E1 osteoblast cell lines, localized on the cell membrane, cytoplasm, and nucleus, similarly to its localization in endothelial cells. PTN causes a small decrease in osteoblast proliferation, which is statistically significant only in MC3T3-E1 pro-osteoblasts, statistically significantly decreases the migration of all osteoblast cell lines studied, while induces the differentiation of MC3T3-E1 pro-osteoblasts to mature osteoblasts. In human prostate cancer PC3 cells, a decrease in PTN expression leads to induction of apoptosis and a reduction in the adhesion of cancer cells to osteoblasts. To elucidate the PTN receptors involved in this adhesion, it was found using many different experimental approaches that PTN selectively interacts with high affinity with VEGFR2 in osteoblasts and endothelial cells. PTN appears to bind through its N-terminus site to the VEGFR2, at a site that affects VEGF-A binding, and reduces VEGFR2 phosphorylation induced by VEGF-A165. This interaction explains the inhibitory effect of PTN on osteoblast migration, but not the stimulatory effect on endothelial cells migration, which is mediated by integrin ανβ3. A neutralizing monoclonal antibody that binds to the extracellular domain of VEGFR2 or silencing VEGFR2 with siRNA lead to enhanced cell migration, which is inhibited by a neutralizing antibody that inhibits integrin αvβ3 or by a PTN peptide corresponding to its carboxy terminus that also inhibits ανβ3 integrin. Finally, using peptides that correspond to different regions of the PTN protein and inhibit its interaction with different receptors, as well as using pharmacological inhibitors of different PTN receptors, it was found that membrane nucleolin is the receptor involved in the adhesion of prostate cancer cells with osteoblasts. The thesis also identified peptides that warrant further studies as potential inhibitors of angiogenesis and/or prostate cancer cell metastasis to bone.
Degree
thesis:*- Grantor dc:publisher
- University of Patras
- Year dc:date
- 2020
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Lamprou, Margarita
- Λάμπρου, Μαργαρίτα
Subjects
dc:subject × 10Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48095